 FORT COLLINS, Colo., Aug. 11, 2021 PRNewswire -- Cytocom, Inc. NASDAQ: CBLI, a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that the company will participate at the Empowering the Kingdom through Business Conference hosted by the Liberty University School of Business on August 10-12, 2021. 